Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
A Keresteci, C Coteli, H Yorgun, K Aytemir · 2026
Read Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy by A Keresteci, C Coteli, H Yorgun, K Aytemir (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13300178.txt.
Description
A Keresteci and co-authors present a 2026 retrospective study of catheter ablation for sustained ventricular tachycardia in hypertrophic cardiomyopathy, a genetic heart muscle disease tied to sudden death. Defibrillators prevent many deaths, yet some patients still receive repeated shocks from fast rhythms. The authors reviewed sixteen patients treated at a university electrophysiology unit between January 2017 and December 2024.
The group averaged about fifty-one years of age, and three quarters were men. Most had an implanted defibrillator, and low-voltage scar was found in half, mainly near the apex and septum. Over a mean follow-up near fifty months, seven patients had a recurrence, and no major procedural complications occurred. The authors judge ablation feasible and reasonably safe for selected patients with recurrent tachycardia.
Catalog record
| CREATOR | A Keresteci, C Coteli, H Yorgun, K Aytemir |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |